Format

Send to

Choose Destination
Curr Opin Clin Nutr Metab Care. 2009 Sep;12(5):515-21. doi: 10.1097/MCO.0b013e32832e1b14.

Endocrine and metabolic response to gastric bypass.

Author information

1
Department of Surgery, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.

Abstract

PURPOSE OF REVIEW:

Diabetes resolves in 80% of individuals undergoing successful Roux-en-Y gastric bypass. Absolute caloric restriction alone resulting from gastric anatomic changes indeed leads to weight loss; however, immediate effects in glycemic control often precede substantial weight loss typically associated with insulin sensitivity. One putative explanation relates to hormonal effects accompanying Roux-en-Y gastric bypass. We reviewed the existing and recent literature to investigate the hormonal changes accompanying Roux-en-Y gastric bypass.

RECENT FINDINGS:

Changes in levels of five candidate enteric hormones have been recently associated with early postoperative glycemic control following Roux-en-Y gastric bypass; the strongest effects are seen with variations in glucagon-like peptide-1, glucose-dependent insulinotropic peptide and ghrelin.

SUMMARY:

The unique hybridization of static anatomic restriction and dynamic absorptive bypass lends a duality to the beneficial effects of Roux-en-Y gastric bypass. This duality likely explains the short-term and long-term resolution of diabetes in patients undergoing Roux-en-Y gastric bypass.

PMID:
19535977
PMCID:
PMC3795522
DOI:
10.1097/MCO.0b013e32832e1b14
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Wolters Kluwer Icon for PubMed Central
Loading ...
Support Center